AVASTIN – A Drug That Should Not Have Been Approved
In 2008, the FDA gave Avastin “accelerated approval” for breast cancer treatment on a “compassionate” basis. This was an injustice done to women with advanced breast cancer. A year before that, I predicted that this drug (and other drugs in its class) will prove to be failed drugs. On December 16, 2010, that prediction was validated. The FDA revoked its
Read more